NCT03132701

Brief Summary

Evaluation of prevention of emergence delirium and analgesic effect of magnesium on children

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 28, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

June 8, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2017

Completed
Last Updated

August 2, 2018

Status Verified

August 1, 2018

Enrollment Period

6 months

First QC Date

April 9, 2017

Last Update Submit

August 1, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Emergence delirium

    Pediatric Anesthesia Emergence Delirium (PAED) scale

    30 minutes after anesthesia

Secondary Outcomes (4)

  • Pain score

    At each two points: during emergence in operating room and 30 minutes after surgery ends

  • Nausea

    At each two points: during emergence in operating room and 30 minutes after surgery ends

  • vomiting

    At each two points: during emergence in operating room and 30 minutes after surgery ends

  • Duration of post-anesthetic care unit (PACU) stay

    During 1 hour after surgery at PACU

Study Arms (2)

Magnesium group

ACTIVE COMPARATOR

Mg is administered with dose of 30 mg/kg for 10 minutes and then 10 mg/kg/hr until 5 minutes before surgery ends

Drug: Magnesium

Control group

PLACEBO COMPARATOR

Saline is administered with same volume of Mg of magnesium group until 5 minutes before surgery ends

Drug: Saline

Interventions

Mg is administered during anesthesia until 5 minutes before surgery ends

Also known as: Magnesium sulfate
Magnesium group
SalineDRUG

Same volume of saline is infused until 5 minutes before surgery ends

Also known as: Normal saline
Control group

Eligibility Criteria

Age2 Years - 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged between 2 and 7 years
  • American Society of Anesthesiologist physical status 1 and 2
  • Children scheduled for opthalmic surgery

You may not qualify if:

  • Allergy history to any drugs
  • Risk of malignant hyperthermia
  • Neuromuscular disease
  • With arrhythmia
  • Any pulmonary, cardiac, hepatic and renal disease
  • Obesity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SNUH

Seoul, Jongro Gu, 15710, South Korea

Location

Related Publications (1)

  • Lee JH, Choi S, Lee M, Jang YE, Kim EH, Kim JT, Kim HS. Effect of magnesium supplementation on emergence delirium and postoperative pain in children undergoing strabismus surgery: a prospective randomised controlled study. BMC Anesthesiol. 2020 Nov 18;20(1):289. doi: 10.1186/s12871-020-01192-7.

MeSH Terms

Conditions

Emergence Delirium

Interventions

MagnesiumMagnesium SulfateSodium ChlorideSaline Solution

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Metals, Alkaline EarthElementsInorganic ChemicalsMetals, LightMetalsMagnesium CompoundsSulfatesSulfuric AcidsSulfur AcidsSulfur CompoundsChloridesHydrochloric AcidChlorine CompoundsSodium CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Hee-Soo Kim

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 9, 2017

First Posted

April 28, 2017

Study Start

June 8, 2017

Primary Completion

December 12, 2017

Study Completion

December 12, 2017

Last Updated

August 2, 2018

Record last verified: 2018-08

Locations